San Francisco, CA, United States of America

Cara B Marks

This inventor holds 6 USPTO granted patents, plus 1 CIPO patent. Top assignees: Genentech, Inc., Other. Active years: 1990-1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cara B Marks. Retrieved from https://idiyas.com/inventor/cara-b-marks

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 2.7

ph-index = 3

Forward Citations = 52(Granted Patents)


Location History:

  • Lawrence, NY (US) (1990)
  • San Francisco, CA (US) (1991 - 1998)

Company Filing History:


Years Active: 1990-1998

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Cara B Marks

Introduction

Cara B Marks is a prominent inventor based in San Francisco, CA, known for her significant contributions to the field of biotechnology. With a total of six patents to her name, she has made remarkable advancements in the development of human tissue plasminogen activator variants. Her work has the potential to impact medical treatments and improve patient outcomes.

Latest Patents

Marks' latest patents include novel variants of tissue plasminogen activator (t-PA) that exhibit surprising biological and pharmacokinetic properties compared to native t-PA. These variants demonstrate increased half-life profiles and maintain good fibrin binding activity, even with the deletion of fibrin binding regions of the molecule. The patents also disclose associated means and methods for preparing these variants recombinantly and for utilizing them effectively in medical applications.

Career Highlights

Throughout her career, Cara B Marks has worked with notable companies, including Genentech, Inc. Her experience in these leading organizations has allowed her to refine her skills and contribute to groundbreaking research in biotechnology.

Collaborations

Marks has collaborated with esteemed colleagues such as Stephen P Anderson and Deborah L Higgins, further enhancing her innovative work in the field.

Conclusion

Cara B Marks continues to be a driving force in the development of advanced medical treatments through her innovative patents and collaborations. Her contributions are paving the way for future advancements in biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…